publication venue for
- Recommendations from a Canadian Delphi consensus study on best practice for optimal referral and appropriate management of severe asthma. 19:12. 2023
- Allergen bronchoprovocation: correlation between FEV1 maximal percent fall and area under the FEV1 curve and impact of allergen on recovery. 19:8. 2023
- Minimization of ragweed allergy immunotherapy costs through use of the sublingual immunotherapy tablet in Canadian children with allergic rhinoconjunctivitis. 19:7. 2023
- Geographical discrepancy in oral food challenge utilization based on Canadian billing data. 19:5. 2023
- International recommendations on epinephrine auto-injector doses often differ from standard weight-based guidance: a review and clinical proposals. 18:102. 2022
- CFTR heterozygosity in severe asthma with recurrent airway infections: a retrospective review. 18:46. 2022
- Lessons learned in allergy and immunology training: a survey analysis. 18:7. 2022
- Modified oral food challenge protocol approach in the diagnosis of Food Protein-Induced Enterocolitis Syndrome. 18:8. 2022
- Physician vaccination practices in mild to moderate inborn errors of immunity and retrospective review of vaccine completeness in IEI: results from the Canadian Immunization Research Network. 18:32. 2022
- Telemedicine in allergy/immunology in the era of COVID-19: a Canadian perspective. 18:16. 2022
- The need for a food allergy educator program for allied healthcare professionals in Canada. 18:62. 2022
- Transitioning subcutaneous immunoglobulin 20% therapies in patients with primary and secondary immunodeficiencies: Canadian real-world study. 18:70. 2022
- CSACI position statement: transition recommendations on existing epinephrine autoinjectors. 17:130. 2021
- Comparison of weight per volume and protein nitrogen units in non-standardized allergen extracts: implications for prescribing subcutaneous immunotherapy. 17:92. 2021
- Demographic characteristics associated with food allergy in a Nationwide Canadian Study. 17:72. 2021
- Effect of omalizumab for autoimmune progesterone dermatitis refractory to bilateral oophorectomy: a case report. 17:58. 2021
- Liver enzyme elevation and eosinophilia with atorvastatin: a case of probable DRESS without cutaneous symptoms. 17:81. 2021
- Neonatal abstinence syndrome is a potential cause of low TREC copy number. 17:115. 2021
- Practical challenges in oral immunotherapy resolved through patient-centered care. 17:31. 2021
- Rupatadine to prevent local allergic reactions to sublingual allergy immunotherapy: a case series. 17:125. 2021
- Systemic reactions to subcutaneous allergen immunotherapy: real-world cause and effect modelling. 17:65. 2021
- Targeting the IL-5 pathway in eosinophilic asthma: a comparison of mepolizumab to benralizumab in the reduction of peripheral eosinophil counts. 17:3. 2021
- The pharmacokinetics of epinephrine/adrenaline autoinjectors. 17:25. 2021
- Underestimation of airway luminal eosinophilia by quantitative sputum cytometry. 17:63. 2021
- A contemporary look at allergic conjunctivitis. 16:5. 2020
- A single centre retrospective study of systemic reactions to subcutaneous immunotherapy. 16:93. 2020
- Adults with possible food protein-induced enterocolitis syndrome with crustacean ingestion. 16:99. 2020
- CSACI guidelines for the ethical, evidence-based and patient-oriented clinical practice of oral immunotherapy in IgE-mediated food allergy. 16:20. 2020
- Co-occurrence between C1 esterase inhibitor deficiency and autoimmune disease: a systematic literature review. 16:41. 2020
- Correction to: The International/Canadian Hereditary Angioedema Guideline. 16:33. 2020
- Epinephrine auto-injector needle length. 16:24. 2020
- Presence of positive skin prick tests to inhalant allergens and markers of T2 inflammation in subjects with chronic spontaneous urticaria (CSU): a systematic literature review. 16:72. 2020
- Changing the culture is a marathon not a sprint. 15:8. 2019
- Omalizumab in patients with severe asthma and persistent sputum eosinophilia. 15:21. 2019
- The International/Canadian Hereditary Angioedema Guideline. 15:72. 2019
- Use of a vibrating mesh nebulizer for allergen challenge. 15:73. 2019
- Whole blood vs PBMC: compartmental differences in gene expression profiling exemplified in asthma. 15:67. 2019
- A multi-stakeholder perspective on asthma care in Canada: findings from a mixed methods needs assessment in the treatment and management of asthma in adults. 14:36. 2018
- CSACI position statement: prescribing sublingual immunotherapy tablets for aeroallergens. 14:1. 2018
- Eligibility of monoclonal antibody-based therapy for patients with severe asthma: a Canadian cross-sectional perspective. 14:68. 2018
- Loss of bronchoprotection to Salbutamol during sputum induction with hypertonic saline: implications for asthma therapy. 14:26. 2018
- Unintentional injection to the bone with a pediatric epinephrine auto-injector. 14:32. 2018
- Allergen-specific immunotherapy. 14:53. 2018
- Allergic rhinitis. 14:51. 2018
- An introduction to immunology and immunopathology. 14:49. 2018
- Anaphylaxis. 14:54. 2018
- Asthma. 14:50. 2018
- IgE-mediated food allergy. 14:55. 2018
- Introduction from the Editors. 14:48. 2018
- Non-IgE-mediated food hypersensitivity. 14:56-56. 2018
- Airway autoimmune responses in severe eosinophilic asthma following low-dose Mepolizumab therapy. 13:2. 2017
- Asthma biomarkers in the age of biologics. 13:48. 2017
- Consumer preferences for food allergen labeling. 13:19. 2017
- Erratum to: Do epinephrine auto-injectors have an unsuitable needle length in children and adolescents at risk for anaphylaxis from food allergy?. 13:33. 2017
- High rate of house dust mite sensitization in a shrimp allergic southern Ontario population. 13:5. 2017
- Management of chronic spontaneous urticaria (CSU): a treat to target approach using a patient reported outcome. 13:38. 2017
- Prediction of clinical peanut allergy status among children in Hamilton, Ontario using chart review data collected during 2012–2015. 13:10. 2017
- Sputum cell counts to manage prednisone-dependent asthma: effects on FEV1 and eosinophilic exacerbations. 13:17. 2017
- Canadian Society of Allergy and Clinical Immunology annual scientific meeting 2016. 13:16. 2017
- Primum non nocere—first do no harm. And then feed peanut. 13:7-7. 2017
- Do epinephrine auto-injectors have an unsuitable needle length in children and adolescents at risk for anaphylaxis from food allergy?. 12:11. 2016
- Allergen immunotherapy in pregnancy. 11:31. 2015
- CSACI position statement: epinephrine auto-injectors and children < 15 kg. 11:20. 2015
- CSACI position statement: systemic effect of inhaled corticosteroids on adrenal suppression in the management of pediatric asthma. 11:9. 2015
- Insights and advances in chronic urticaria: a Canadian perspective. 11:7. 2015
- The Allergic Rhinitis – Clinical Investigator Collaborative (AR-CIC): nasal allergen challenge protocol optimization for studying AR pathophysiology and evaluating novel therapies. 11:16. 2015
- Therapeutic potential of anti-IL-6 therapies for granulocytic airway inflammation in asthma. 11:14. 2015
- 10th anniversary of allergy, asthma & clinical immunology. 10:51. 2014
- A retrospective study of the clinical benefit from acetylsalicylic acid desensitization in patients with nasal polyposis and asthma. 10:64. 2014
- Anaphylaxis-related deaths in Ontario: a retrospective review of cases from 1986 to 2011. 10:38. 2014
- Auto-injector needle length may be inadequate to deliver epinephrine intramuscularly in women with confirmed food allergy. 10:39. 2014
- Blood biomarkers of the late phase asthmatic response using RNA-Seq. 10:A61-A61. 2014
- Canadian hereditary angioedema guideline. 10:50. 2014
- Children under 15 kg with food allergy may be at risk of having epinephrine auto-injectors administered into bone. 10:40. 2014
- Co-exposure to allergen and diesel exhaust enhance inflammatory responses in human airway submucosa. 10:a57. 2014
- Dietary exposures and allergy prevention in high-risk infants: a joint position statement of the Canadian Society of Allergy and Clinical Immunology and the Canadian Paediatric Society. 10:45. 2014
- Efficacy and safety of ragweed sublingual immunotherapy in Canadian patients with allergic rhinoconjunctivitis. 10:55. 2014
- IL-4 and IL-13 regulate TLR expression and eosinophil-basophil differentiation of cord blood CD34+ progenitor cells. 10:a60. 2014
- Patients on subcutaneous allergen immunotherapy are at risk of intramuscular injections. 10:22. 2014
- Reconciliation of health records following penicillin allergy testing of hospitalized patients. 10:a39. 2014
- Th17/Treg ratio derived using DNA methylation analysis is associated with the late phase asthmatic response. 10:32. 2014
- The Allergic Rhinitis - Clinical Investigator Collaborative (AR-CIC) - optimizing the Nasal Allergen Challenge (NAC) model. 10:a62. 2014
- The early life gut microbiota and atopic disease. 10:A63-A63. 2014
- The efficacy and safety of the Timothy grass allergy sublingual immunotherapy tablet in Canadian adults and children. 10:53. 2014
- Transcriptional networks in whole blood of asthmatics. 10:a58. 2014
- Value of skin testing children with a family history of food allergy before ingestion of suspect food allergens. 10:a29. 2014
- Are known biomarkers for asthma present in early infancy?. 10:A48-A48. 2014
- Comparison of questionnaire responses with biomarkers of tobacco smoke exposure in a Canadian birth cohort at three months of age. 10:A60-A60. 2014
- Th17/Treg ratio derived using DNA methylation analysis discriminates allergen-induced early from dual asthmatic responses. 10:A46-A46. 2014
- Association between low vitamin D levels and the diagnosis of asthma in children: a systematic review of cohort studies. 10:31-31. 2014
- A practical guide to the monitoring and management of the complications of systemic corticosteroid therapy. 9:30. 2013
- CSACI position statement: safety of topical calcineurin inhibitors in the management of atopic dermatitis in children and adults. 9:24. 2013
- Experiencing a first food allergic reaction: a survey of parent and caregiver perspectives. 9:18. 2013
- Infant gut microbiota and the hygiene hypothesis of allergic disease: impact of household pets and siblings on microbiota composition and diversity. 9:15. 2013
- Newly diagnosed chronic granulomatous disease in a 44 year old male presenting with recurrent groin cellulitis and colitis. 9:9. 2013
- Proposed new mechanism for food and exercise induced anaphylaxis based on case studies. 9:11. 2013
- The effects of rituximab on serum IgE and BAFF. 9:39. 2013
- The utility of using fiberoptic rhinoscopy in the diagnosis of nasal polyps. 9:38. 2013
- Local and systemic immunological parameters associated with remission of asthma symptoms in children. 8:16. 2012
- Management of anaphylaxis in schools: Evaluation of an epinephrine auto-injector (EpiPen®) use by school personnel and comparison of two approaches of soliciting participation. 8:4. 2012
- Skin prick testing with extensively heated milk or egg products helps predict the outcome of an oral food challenge: a retrospective analysis. 8:5. 2012
- The burden of allergic rhinitis (AR) in Canada: perspectives of physicians and patients. 8:7. 2012
- Adrenal suppression: A practical guide to the screening and management of this under-recognized complication of inhaled corticosteroid therapy. 7:13. 2011
- Allergen-specific immunotherapy. 7:S5. 2011
- Allergic rhinitis. 7:S3. 2011
- An introduction to immunology and immunopathology. 7:S1. 2011
- Anaphylaxis. 7:S6. 2011
- Asthma. 7:S2. 2011
- Canadian clinical practice guidelines for acute and chronic rhinosinusitis. 7:2. 2011
- Comparative responses to nasal allergen challenge in allergic rhinitic subjects with or without asthma. 7:8. 2011
- Food allergy. 7:S7. 2011
- Introduction from the Editors. 7:I1. 2011
- Mucosal exposure to cockroach extract induces allergic sensitization and allergic airway inflammation. 7:22. 2011
- The identification of eosinophilic gastroenteritis in prednisone-dependent eosinophilic bronchitis and asthma. 7:4. 2011
- 2010 International consensus algorithm for the diagnosis, therapy and management of hereditary angioedema. 6:24. 2010
- Food allergy management from the perspective of patients or caregivers, and allergists: a qualitative study. 6:30. 2010
- Food allergy management from the perspective of patients, caregivers and allergists: a qualitative study. 6:p8. 2010
- Omalizumab: Practical considerations regarding the risk of anaphylaxis. 6:32. 2010
- Skin prick testing in patients using beta-blockers: a retrospective analysis. 6:2. 2010
- Canadians' perception of food allergy risk. 6:p31. 2010
- Estimating the prevalence of milk, egg, and wheat allergies in the Canadian population. 6:p37. 2010
- Assessing a community-based asthma education intervention. 6:p9. 2010
- Assessing a population-based approach to the management of respiratory disease. 6:p11. 2010
- Hodgkin's lymphoma presenting with markedly elevated IgE: a case report. 5:12. 2009
- Psychological Factors in Asthma. 4:12-28. 2008
- Psychological factors in asthma. 4:12-28. 2008
- The mind-body of allergic diseases. 4:1. 2008
- Immunotherapy with Allergen Peptides. 03:53-53. 2007
- Immunotherapy with Allergen Peptides. 3:53-59. 2007
- Consensus Guidelines on Practical Issues of Immunotherapy-Canadian Society of Allergy and Clinical Immunology (CSACI). 2:47-61. 2006
- Consensus Guidelines on Practical Issues of Immunotherapy–Canadian Society of Allergy and Clinical Immunology (CSACI). 02:47-47. 2006
- Linear IgA dermatosis: An unusual case involving the oral mucosa and possible association with perindopril therapy. 5:203-208. 2000
- Hemopoietic mechanisms in nasal polyposis and asthma. 5:233-236. 2000
- Letter to the editor. 4:6. 1999
- Stroke following intravenous immunoglobulin infusion in a 28-year-old male with common variable immune deficiency: A case report and literature review. 4:250-253. 1999
- AllerGen’s 8th research conference 2016
- President's message 2007